(Q48538982)

12 February 2018

title

Lymphocytes sensitised to basic encephalitogen in patients with multiple sclerosis unresponsive to steroid therapy. (English)

1 reference

12 February 2018

0 references

C Webb

1

1 reference

12 February 2018

D Teitelbaum

2

1 reference

12 February 2018

O Abramsky

3

1 reference

12 February 2018

R Arnon

4

1 reference

12 February 2018

M Sela

5

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 July 1974

1 reference

12 February 2018

published in

The Lancet

1 reference

12 February 2018

volume

2

1 reference

12 February 2018

issue

7872

1 reference

12 February 2018

page(s)

66-69

1 reference

12 February 2018

Basic proteins from the acidic extract of bovine spinal cord

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Immune processes and infectious factors in central nervous system disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Search for anti-encephalitogen antibody in human demyelinative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

<i>In vitro</i> Delayed (Cellular) Hypersensitivity in Multiple Sclerosis to Central Nervous System Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Delayed hypersensitivity to myelin antigen in multiple sclerosis investigated with the leucocyte migration method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Lymphocyte sensitisation: an in-vitro test for cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Transformation of lymphocytes from patients with multiple sclerosis. Use of encephalitogen of human origin, with a report of a trial of immunosuppressive therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Lymphocyte Transformation in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Basic encephalitogenic protein: A simplified purification on sulphoethyl-sephadex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Stimulation of rat lymphocyte proliferation by hydrocortisone during the induction of cell-mediated immunity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

Long-term treatment of multiple sclerosis with corticotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2991633-X

7 January 2021

10.1016/S0140-6736(74)91633-X

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018